tradingkey.logo
tradingkey.logo
Suchen

CeriBell Inc

CBLL
Zur Watchlist hinzufügen
19.550USD
-0.450-2.25%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
741.78MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über CeriBell Inc Unternehmen

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc Informationen

BörsenkürzelCBLL
Name des UnternehmensCeribell Inc
IPO-datumOct 11, 2024
CEOChao (Xingjuan)
Anzahl der mitarbeiter281
WertpapierartOrdinary Share
GeschäftsjahresendeOct 11
Addresse360 N. Pastoria Avenue
StadtSUNNYVALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94085
Telefon18004360826
Websitehttps://ceribell.com/
BörsenkürzelCBLL
IPO-datumOct 11, 2024
CEOChao (Xingjuan)

Führungskräfte von CeriBell Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.03M
-1.36%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
143.70K
-1.37%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
95.85K
-1.45%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
25.23K
+31.07%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.03M
-1.36%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
143.70K
-1.37%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
95.85K
-1.45%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
25.23K
+31.07%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von CeriBell Inc?

Die fünf größten Anteilseigner von CeriBell Inc sind: Dr. Josef Parvizi, M.D., Ph.D.

Wie viele Institutionen halten Anteile an CeriBell Inc (CBLL)?

Mit Stand vom 2026Q1 halten 236 Institutionen Anteile an CeriBell Inc, mit einem Gesamtmarktwert von etwa 31.90M, was 84.99% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1637325.00 gestiegen.

Was ist die größte Einnahmequelle von CeriBell Inc?

Am 2026Q1 erzielte das Geschäft mit EEG recorders and EEG headbands, point in time für CeriBell Inc den höchsten Umsatz in Höhe von 67.33M, was 75.60% des Gesamtumsatzes entspricht.